Table Of Contents:
1. Low-dose Naltrexone Therapy for Psoriasis
2. Compounding Pearls -- Wound Care: Base Selection
3. Compounding Pearls -- Wound Care: Base Selection
4. A "North Star" for Pharmacy Compounders
5. Basics of Nonsterile Compounding: Excipients Used in Nonsterile Compounding, Part 5: Compounding Using Solvents and Cosolvent Systems
6. Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities
7. Calculations
8. Acetazolamide 25 mg/mL in SyrSpend SF pH4
9. Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4
10. Glycopyrrolate 0.2 mg/mL in Ora-Plus:Ora-Sweet (1:1)
11. Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4
12. Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension
13. Propylthiouracil 5 mg/mL in SyrSpend SF pH4
14. Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4
15. Terbinafine 25 mg/mL in SyrSpend SF pH4
16. Topiramate 5 mg/mL in SyrSpend SF pH4
17. Valsartan 4 mg/mL in Syrup NF
18. The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment
19. Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets
20. Physicochemical Stability of Ternary Mixtures of Sufentanil, Baclofen, and Ropivacaine in Polypropylene Syringes for Intrathecal Analgesia
21. Feasibility Study of Asthma Cream
22. Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel